These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7125868)

  • 41. Biopharmaceutical investigation of rectal suppositories. Part 2(1): Pharmaceutical and biological availability of phenobarbital and phenobarbital-sodium.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1985 Apr; 40(4):257-9. PubMed ID: 3839310
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Formulation and analysis of suppositories containing papaverine hydrochloride. Part 1. Choice of the optimal vehicle and determination of the physical parameters of the suppositories].
    Regdon G; Vastag T; Regdon G; Selmeczi B
    Acta Pharm Hung; 1991 Nov; 61(6):295-302. PubMed ID: 1785358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [On a new suppositories-base].
    Lietz G
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1968 May; 38(5):93-5. PubMed ID: 5755847
    [No Abstract]   [Full Text] [Related]  

  • 44. Suppository formulations as a potential treatment for nephropathic cystinosis.
    Buchan B; Kay G; Matthews KH; Cairns D
    J Pharm Sci; 2012 Oct; 101(10):3729-38. PubMed ID: 22778070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The solubility of drugs in molten suppository bases].
    Pflegel P; Schöbel H; Klaus T; Raguse U
    Pharmazie; 1990 Apr; 45(4):266-7. PubMed ID: 2381978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physical parameters of chlorphenamine maleate suppositories and its release as a function of particle size, concentration and nature of the base.
    el-Din EN; Mursi NM; Elbary AA; Foda N
    Pharmazie; 1977; 32(8-9):515-7. PubMed ID: 594118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Studies of the rectal resorption of strychnine sulfate from suppositories prepared with indigenous excipients].
    Verbuţă A; Pavelescu M; Moisă L
    Rev Med Chir Soc Med Nat Iasi; 1976; 80(3):437-40. PubMed ID: 1024240
    [No Abstract]   [Full Text] [Related]  

  • 48. [Tween 61 excipient base for suppositories].
    ROTTEGLIA E
    Boll Chim Farm; 1950 Sep; 89(9):368-74. PubMed ID: 14791648
    [No Abstract]   [Full Text] [Related]  

  • 49. [ON THE COMPATIBILITY OF AMINOSINE SUPPOSITORIES].
    MEIER HJ
    Z Arztl Fortbild (Jena); 1964 Mar; 58():352-4. PubMed ID: 14171609
    [No Abstract]   [Full Text] [Related]  

  • 50. [Drug liberation and resorption from fatty bases].
    Wolf C; Voigt R
    Pharmazie; 1968 Jul; 23(7):345-53. PubMed ID: 4882641
    [No Abstract]   [Full Text] [Related]  

  • 51. [Influence of excipients and storage conditions on drug preservation. IV. Suppositories with acetyl salicylic acid base].
    Delonca H; Puech A; Segura G; Joachim J
    J Pharm Belg; 1972; 27(1):50-6. PubMed ID: 5017455
    [No Abstract]   [Full Text] [Related]  

  • 52. [THE PREPARATION AND TESTING OF RECTAL DRUG PREPARATIONS, ESPECIALLY SUPPOSITORIES].
    HEYDENREICH K
    Pharm Prax; 1964; 12():279-83. PubMed ID: 14341498
    [No Abstract]   [Full Text] [Related]  

  • 53. Predictive Evaluation of Pharmaceutical Properties of Ulinastatin-Containing Vaginal Suppositories as a Hospital Preparation by Near-Infrared Spectroscopy.
    Kishino T; Inoue Y; Inoue K; Saito K; Kondo M; Otsuka K; Terukina T; Hattori Y; Otsuka M
    Chem Pharm Bull (Tokyo); 2018; 66(6):589-595. PubMed ID: 29863060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Significance of the degree of molecular order for the usage properties of suppositories].
    Hüttenrauch R; Fricke S
    Pharmazie; 1979; 34(9):579. PubMed ID: 542496
    [No Abstract]   [Full Text] [Related]  

  • 55. [Preparation of theophylline-sodium salicylate suppositories and determination of factors influencing the in vitro dissolution of the active agents].
    Regdon G; Takarò K; Regdon G
    Arch Pharm (Weinheim); 1990 Jul; 323(7):421-5. PubMed ID: 2241535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [USE OF THIN LAYER CHROMATOGRAPHY IN THE ANALYSIS OF DISPENSED SUPPOSITORIES].
    KRAUS L; VEPROVSKA E
    Cesk Farm; 1963 Dec; 12():515. PubMed ID: 14118727
    [No Abstract]   [Full Text] [Related]  

  • 57. [Study of the effects of various surface-active agents on the release of drugs from the excipients in suppositories].
    PAGANI G
    Farmaco Prat; 1959 Dec; 14():765-7. PubMed ID: 13854212
    [No Abstract]   [Full Text] [Related]  

  • 58. [STUDY OF THE PHYSICAL-CHEMICAL PROPERTIES OF POLYETHYLENE OXIDES AS SUPPOSITORY BASES].
    GLUZMAN MKh; DASHEVSKAIA BI; FRIDMAN GM
    Med Prom SSSR; 1965 May; 73():16-22. PubMed ID: 14299120
    [No Abstract]   [Full Text] [Related]  

  • 59. Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories.
    Allen LV
    Int J Pharm Compd; 2022; 26(1):34-38. PubMed ID: 35081043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of drug solubility on in vitro availability rate from suppositories with polyethylene glycol excipients.
    Realdon N; Ragazzi E; Ragazzi E
    Pharmazie; 2001 Feb; 56(2):163-7. PubMed ID: 11234347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.